Table 1 Relationship between TACC3 expression and clinicopathological features of patients with PDAC.

From: Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer

Characteristics

The Pooled(N = 218)

TACC3

P-value

Low (N = 104)

High (N = 114)

Age(years)

   

0.986

≤60

90

43

47

 

<60

128

61

67

 

Gender

   

0.976

Male

126

60

66

 

Female

92

44

48

 

Tumor location

   

0.477

Head and neck

127

58

69

 

Body and tail

91

46

45

 

Neural invasion

   

0.039

No

42

26

16

 

Yes

172

76

96

 

Microvascular invasion

  

0.013

No

149

80

69

 

Yes

57

20

37

 

Tumor differentiation

  

0.029

Poor

75

32

43

 

Moderate

106

47

59

 

Well

37

25

12

 

8th AJCC stage

   

0.005

I

89

52

37

 

II

103

46

57

 

III

26

6

20

 

8th T stage

   

0.012

I

28

20

8

 

II

124

59

65

 

III

66

25

41

 

8th N stage

   

0.027

0

121

67

54

 

1

68

28

40

 

2

29

9

20

 

Preoperative CA19-9 (U/ml)

  

0.042

≤37

48

29

19

 

<37

169

74

95

 

Ki-67

   

<0.001

Low

93

57

36

 

High

77

22

55

Â